Top Markets
Coin of the day
Nanomix Corporation Nanomix Corporation

Nanomix Corporation

NNMX
Rangering i aksjer #41810
Boston Therapeutics, Inc. focuses on the discovery, production, and... Boston Therapeutics, Inc. focuses on the discovery, production, and commercialization of therapeutic drugs aimed at fulfilling critical unmet medical needs in the areas of diabetes and inflammatory diseases. The company's pipeline features BTI-320, a non-systemic, carbohydrate-based tablet currently in Phase II clinical trials, which is being developed to reduce post-meal blood glucose levels in patients with pre-diabetes and type 2 diabetes. They also have IPOXYN, an injectable medication designed to prevent tissue necrosis and address conditions caused by low oxygen, such as diabetic foot ulcers and other related vascular or neurological complications. Additionally, Boston Therapeutics is progressing with BTI-410, a peptide injectable compound also in Phase II clinical development, intended to stimulate beta cell maturation in the pancreas. This could potentially serve as a new insulin-producing cell agent for individuals with type 2 diabetes and type 1 patients on immunosuppression therapy following a kidney transplant. Complementing its pharmaceutical endeavors, the company offers SUGARDOWN, a non-systemic, polysaccharide-based dietary supplement designed to support healthy blood glucose management, and OXYFEX, a veterinary application that acts as an oxygen delivery agent, similar to a red blood cell replacement, for treating ischemia, trauma, and blood loss during surgical procedures. The firm further extends its offerings to include Automatic Retinal Image Analysis (ARIA), a diagnostic tool used for screening cardiovascular risks, including stroke. Boston Therapeutics, Inc. maintains its headquarters in Lawrence, Massachusetts.
Aksjekurs
$0.0002
Sist synkronisert: 2025-04-08
Markedsverdi
$9.80K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Nanomix Corporation (NNMX)

Kategori

Pris NNMX pris med markedsverdi på B
Nanomix Corporation Nanomix Corporation
NNMX
$0.0002
Markedsverdi av Nanomix Corporation(NNMX)
Markedsverdi: $9.80K
Per August 2026 har Nanomix Corporation en markedsverdi på $9.80K. Dette gjør Nanomix Corporation til det 41810th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Nanomix Corporation fra 2021 til 2026
NNMX sammenlignet med topp 5 mest populære stocks
Pris på NNMX Eiendel B Markedsverdi for B Resultater
Nanomix Corporation Nanomix Corporation
$109,876 $9.80K
$5.383T +54,937,845,190.34%
Nanomix Corporation Nanomix Corporation
$90,282.50 $9.80K
$4.423T +45,141,251,086.22%
Nanomix Corporation Nanomix Corporation
$84,914.16 $9.80K
$4.160T +42,457,081,225.46%
Nanomix Corporation Nanomix Corporation
$74,769.28 $9.80K
$3.663T +37,384,639,526.49%
Nanomix Corporation Nanomix Corporation
$59,010.69 $9.80K
$2.891T +29,505,345,296.47%